Clinical Trials Logo

Hemoglobins clinical trials

View clinical trials related to Hemoglobins.

Filter by:

NCT ID: NCT05506748 Completed - Mortality Clinical Trials

Association Between Preoperative HALP and Immediate Postoperative Outcomes

Start date: April 20, 2021
Phase:
Study type: Observational

Multiple inflammation-based prognostic scores have been developed for the prediction of perioperative morbidity and mortality following pancreaticoduodenectomy (PD). Preoperative "Hemoglobin, Albumin, Lymphocytes and Platelets index (HALP)" is one of the promising inflammatory markers that has emerged as a predictor of postoperative survival. To date, no study has been done with preoperative HALP to predict 30days morbidity and mortality. Is there any association between Preoperative HALP (hemoglobin, albumin, lymphocyte, and platelet) and 30 days post operative morbidity and mortality in patients undergoing Pancreaticoduodenectomy?

NCT ID: NCT04869319 Completed - Hemoglobins Clinical Trials

Electronic Triggers: Messaging After A1C EHR Alert

Start date: July 13, 2020
Phase:
Study type: Observational

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.

NCT ID: NCT04189250 Recruiting - Hemoglobins Clinical Trials

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

The aim of this study is the comparison of two measurement protocols determining hemoglobin mass with two different blood sampling strategies.Both protocols are based on the principle of the carbonmonoxid (CO) rebreathing method. During this measurement, CO is inhaled for a specific time period by the subject in a closed circuit and it is used as a marker to tag circulating hemoglobin.

NCT ID: NCT03816514 Completed - Hemorrhage Clinical Trials

Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range

Start date: March 4, 2019
Phase: N/A
Study type: Interventional

The primary aim of this study is to evaluate whether pulse oximetry based noninvasive hemoglobin (SpHb) monitoring can reduce the incidence of hemoglobin (Hb) level out of the target range in adult patients undergoing major surgery with the potential risk of bleeding.

NCT ID: NCT02876627 Completed - Cancer Clinical Trials

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

Start date: February 2015
Phase: Phase 1
Study type: Interventional

Introduction: The purpose of this study was to determine the effect of twelve weeks of aerobic exercise program on erythrocyte levels in women with breast cancer after chemotherapy. Methods: Thirty women with breast cancer after chemotherapy of Sydalshhda hospital (aged between 47-65 years) volunteered for this study, and then randomly selected an exercise (n = 15) and control (n = 15) groups. Exercise group completed a twelve-week aerobic exercise training program consisted of three sessions per week, each session lasting 30 to 60 minutes 50 to 75 percent of their maximum heart rate reserve, while the control group were followed. Blood samples including red blood cell counts (RBC), hematocrit (HCT), hemoglobin (HB), peak oxygen consumption before and after 12 weeks of aerobic exercise were measured. For analysis of data, repeated-measures analysis of variance (ANOVA) was used.

NCT ID: NCT02722759 Completed - Infant Clinical Trials

Haemoglobin Measurement for Babies

Start date: March 2016
Phase: N/A
Study type: Interventional

In this prospective study different methods of haemoglobin measurement in term and preterm neonates are compared with the gold standard. Non-invasive haemoglobin measurement with the Radical-7® (SpHb, Masimo®), point-of-care haemoglobin-measurement (HcHb, HemoCue@, Radiometer), blood-gas-analysis (BGAHb,ABL800®, Radiometer) are compared with haemoglobin measurement by an automated hematology analyzer (labHb, Siemens Advia®).

NCT ID: NCT02655107 Completed - Hemoglobins Clinical Trials

Non-invasive Measurement of Hemoglobin in Infants and Neonates

Start date: February 2015
Phase: N/A
Study type: Observational

Non-invasive measurement of hemoglobin in infants and neonates scheduled for elective congenital heart surgery, weighing between 3kg and 20 kg. SpHb measurement will be compared to the gold standard of hemoglobin measurement - CO-oximetrie - and to the point-of-care (GEM 3500 premiere).

NCT ID: NCT01529502 Completed - Inflammation Clinical Trials

Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting

Start date: March 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether storage time affects how human body responds to autologous blood transfusion. An autologous blood transfusion is when a person donates blood and then receives that same blood back in the transfusion. We also want to find out if in this situation inhaled nitric oxide can help to prevent the potential reduction of vasodilation capacity. Vasodilation capacity is the ability of the blood vessel to widen when needed.

NCT ID: NCT00246597 Terminated - Quality of Life Clinical Trials

A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether it is possible to measure temporary difficulty with thinking and/or short-term memory in women who are receiving chemotherapy for early stage breast cancer and to determine whether or not treatment with PROCRIT® will help decrease any problems with thinking or short-term memory that chemotherapy may cause.

NCT ID: NCT00228995 Terminated - Anemia Clinical Trials

A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia

Start date: June 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess changes in physical function in elderly patients (>= 65 years of age) with chronic anemia (Hb <= 11.0 g/dL) due to anemia of unknown cause and receiving weekly subcutaneous doses of Epoetin alfa (PROCRIT®) versus placebo.